Umbilical cord-derived stem cell therapy (TricelX)

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameUmbilical cord-derived stem cell therapy (TricelX)
Drug Alias NameXytriX
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTricelX Inc
China Registration ClassN/A

Develop Information

Active CompaniesTricelX Inc
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A